OrganoTherapeutics has the mission to accelerate the development of therapeutics against neurodegeneration.

Our team is convinced that therapeutics targeting complex human diseases - like Parkinson’s - need to be developed using complex human patient-specific models. That is why we offer tailored research projects from experiments to data analysis and interpretation.

Our team has developed Parkinson’s Disease patient-specific cell culture models, organoids and assembloids, that replicate the Parkinson’s pathology and, to an extent, that cannot be found in any other cell culture or animal model. 

The organoid and assembloid models are IP-protected and have been used in the past 6 years in joint projects with academic and industry partners from Europe, the USA and Japan.